{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T18:50:06Z","timestamp":1791571806310,"version":"4.3.4"},"reference-count":89,"publisher":"American Society of Hematology","issue":"9","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2016,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Peripheral T-cell lymphomas (PTCLs) represent a heterogeneous group of T-cell malignancies that generally demonstrate aggressive clinical behavior, often are refractory to standard therapy, and remain significantly understudied. The most common World Health Organization subtype is PTCL, not otherwise specified (NOS), essentially a \u201cwastebasket\u201d category because of inadequate understanding to assign cases to a more specific diagnostic entity. Identification of novel fusion genes has contributed significantly to improving the classification, biologic understanding, and therapeutic targeting of PTCLs. Here, we integrated mate-pair DNA and RNA next-generation sequencing to identify chromosomal rearrangements encoding expressed fusion transcripts in PTCL, NOS. Two of 11 cases had novel fusions involving VAV1, encoding a truncated form of the VAV1 guanine nucleotide exchange factor important in T-cell receptor signaling. Fluorescence in situ hybridization studies identified VAV1 rearrangements in 10 of 148 PTCLs (7%). These were observed exclusively in PTCL, NOS (11%) and anaplastic large cell lymphoma (11%). In vitro, ectopic expression of a VAV1 fusion promoted cell growth and migration in a RAC1-dependent manner. This growth was inhibited by azathioprine, a clinically available RAC1 inhibitor. We also identified novel kinase gene fusions, ITK-FER and IKZF2-ERBB4, as candidate therapeutic targets that show similarities to known recurrent oncogenic ITK-SYK fusions and ERBB4 transcript variants in PTCLs, respectively. Additional novel and potentially clinically relevant fusions also were discovered. Together, these findings identify VAV1 fusions as recurrent and targetable events in PTCLs and highlight the potential for clinical sequencing to guide individualized therapy approaches for this group of aggressive malignancies.<\/jats:p>","DOI":"10.1182\/blood-2016-03-707141","type":"journal-article","created":{"date-parts":[[2016,6,14]],"date-time":"2016-06-14T02:33:56Z","timestamp":1465871636000},"page":"1234-1245","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":109,"title":["Integrated mate-pair and RNA sequencing identifies novel, targetable gene fusions in peripheral T-cell lymphoma"],"prefix":"10.1182","volume":"128","author":[{"given":"Rebecca L.","family":"Boddicker","sequence":"first","affiliation":[{"name":"Department of Laboratory Medicine and Pathology,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gina L.","family":"Razidlo","sequence":"additional","affiliation":[{"name":"Center for Basic Research in Digestive Diseases, Division of Gastroenterology & Hepatology,"},{"name":"Department of Biochemistry and Molecular Biology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surendra","family":"Dasari","sequence":"additional","affiliation":[{"name":"Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zeng","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine and Pathology,"},{"name":"Department of Pathology, Tongji Hospital, Tongji University School of Medicine, Shanghai, China;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangzhen","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine and Pathology,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan A.","family":"Knudson","sequence":"additional","affiliation":[{"name":"Medical Genome Facility,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia T.","family":"Greipp","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine and Pathology,"},{"name":"Medical Genome Facility,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaime I.","family":"Davila","sequence":"additional","affiliation":[{"name":"Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah H.","family":"Johnson","sequence":"additional","affiliation":[{"name":"Center for Individualized Medicine, and"},{"name":"Department of Molecular Medicine, Mayo Clinic, Rochester, MN;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie C.","family":"Porcher","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine and Pathology,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James B.","family":"Smadbeck","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine and Pathology,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce W.","family":"Eckloff","sequence":"additional","affiliation":[{"name":"Medical Genome Facility,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel D.","family":"Billadeau","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Biology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul J.","family":"Kurtin","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine and Pathology,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"McNiven","sequence":"additional","affiliation":[{"name":"Center for Basic Research in Digestive Diseases, Division of Gastroenterology & Hepatology,"},{"name":"Department of Biochemistry and Molecular Biology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian K.","family":"Link","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of Iowa Hospitals and Clinics, Iowa City, IA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen M.","family":"Ansell","sequence":"additional","affiliation":[{"name":"Division of Hematology and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James R.","family":"Cerhan","sequence":"additional","affiliation":[{"name":"Department of Health Sciences Research, Mayo Clinic, Rochester, MN; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan W.","family":"Asmann","sequence":"additional","affiliation":[{"name":"Department of Health Sciences Research, Mayo Clinic, Jacksonville, FL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Vasmatzis","sequence":"additional","affiliation":[{"name":"Center for Individualized Medicine, and"},{"name":"Department of Molecular Medicine, Mayo Clinic, Rochester, MN;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew L.","family":"Feldman","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine and Pathology,"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"5","key":"2020071613014936700_B1","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1002\/ajh.23144","article-title":"The aggressive peripheral T-cell lymphomas: 2012 update on diagnosis, risk stratification, and management.","volume":"87","author":"Armitage","year":"2012","journal-title":"Am J Hematol"},{"issue":"25","key":"2020071613014936700_B2","doi-asserted-by":"crossref","first-page":"4124","DOI":"10.1200\/JCO.2008.16.4558","article-title":"International peripheral T-cell and natural killer\/T-cell lymphoma study: pathology findings and clinical outcomes.","volume":"26","author":"Vose","year":"2008","journal-title":"J Clin Oncol"},{"issue":"11","key":"2020071613014936700_B3","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1080\/10428190802455867","article-title":"Incidence and outcomes of the peripheral T-cell lymphoma subtypes in the United States.","volume":"49","author":"Abouyabis","year":"2008","journal-title":"Leuk Lymphoma"},{"key":"2020071613014936700_B4","first-page":"306","article-title":"Peripheral T-cell lymphoma, not otherwise specified.","volume-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"Pileri","year":"2008"},{"key":"2020071613014936700_B5","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1182\/asheducation-2009.1.523","article-title":"The 2008 WHO classification of lymphomas: implications for clinical practice and translational research.","volume":"2009","author":"Jaffe","year":"2009","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"2","key":"2020071613014936700_B6","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/his.12251","article-title":"Peripheral T-cell and NK-cell lymphomas and their mimics; taking a step forward - report on the lymphoma workshop of the XVIth meeting of the European Association for Haematopathology and the Society for Hematopathology.","volume":"64","author":"Attygalle","year":"2014","journal-title":"Histopathology"},{"issue":"6","key":"2020071613014936700_B7","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1182\/blood-2008-04-097931","article-title":"Chromosomal translocations: revisited yet again.","volume":"112","author":"Rowley","year":"2008","journal-title":"Blood"},{"issue":"3","key":"2020071613014936700_B8","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/modpathol.3880289","article-title":"Anaplastic large cell lymphoma: the shifting sands of diagnostic hematopathology.","volume":"14","author":"Jaffe","year":"2001","journal-title":"Mod Pathol"},{"issue":"5","key":"2020071613014936700_B9","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1097\/PPO.0b013e31826aef4a","article-title":"Brentuximab vedotin and crizotinib in anaplastic large-cell lymphoma.","volume":"18","author":"Foyil","year":"2012","journal-title":"Cancer J"},{"issue":"11","key":"2020071613014936700_B10","doi-asserted-by":"crossref","first-page":"3913","DOI":"10.1182\/blood.V93.11.3913","article-title":"Prognostic significance of anaplastic lymphoma kinase (ALK) protein expression in adults with anaplastic large cell lymphoma.","volume":"93","author":"Gascoyne","year":"1999","journal-title":"Blood"},{"issue":"5151","key":"2020071613014936700_B11","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1126\/science.8122112","article-title":"Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin\u2019s lymphoma.","volume":"263","author":"Morris","year":"1994","journal-title":"Science"},{"issue":"11","key":"2020071613014936700_B12","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1182\/blood-2012-03-419937","article-title":"Genome-wide analysis reveals recurrent structural abnormalities of TP63 and other p53-related genes in peripheral T-cell lymphomas.","volume":"120","author":"Vasmatzis","year":"2012","journal-title":"Blood"},{"issue":"9","key":"2020071613014936700_B13","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1182\/blood-2014-04-571091","article-title":"ALK-negative anaplastic large cell lymphoma is a genetically heterogeneous disease with widely disparate clinical outcomes.","volume":"124","author":"Parrilla Castellar","year":"2014","journal-title":"Blood"},{"issue":"4","key":"2020071613014936700_B14","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.ccell.2015.03.006","article-title":"Convergent mutations and kinase fusions lead to oncogenic STAT3 activation in anaplastic large cell lymphoma.","volume":"27","author":"Crescenzo","year":"2015","journal-title":"Cancer Cell"},{"issue":"25","key":"2020071613014936700_B15","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1182\/blood-2014-07-588434","article-title":"A novel recurrent NPM1-TYK2 gene fusion in cutaneous CD30-positive lymphoproliferative disorders.","volume":"124","author":"Velusamy","year":"2014","journal-title":"Blood"},{"issue":"2","key":"2020071613014936700_B16","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/sj.leu.2404045","article-title":"Novel t(5;9)(q33;q22) fuses ITK to SYK in unspecified peripheral T-cell lymphoma.","volume":"20","author":"Streubel","year":"2006","journal-title":"Leukemia"},{"issue":"3","key":"2020071613014936700_B17","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1182\/blood-2010-08-303305","article-title":"Discovery of recurrent t(6;7)(p25.3;q32.3) translocations in ALK-negative anaplastic large cell lymphomas by massively parallel genomic sequencing.","volume":"117","author":"Feldman","year":"2011","journal-title":"Blood"},{"issue":"11","key":"2020071613014936700_B18","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1093\/bioinformatics\/btu078","article-title":"BIMA V3: an aligner customized for mate pair library sequencing.","volume":"30","author":"Drucker","year":"2014","journal-title":"Bioinformatics"},{"issue":"15","key":"2020071613014936700_B19","doi-asserted-by":"crossref","first-page":"e100","DOI":"10.1093\/nar\/gkr362","article-title":"A novel bioinformatics pipeline for identification and characterization of fusion transcripts in breast cancer and normal cell lines.","volume":"39","author":"Asmann","year":"2011","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"2020071613014936700_B20","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1309\/PNXUKA1CFJMVGCN1","article-title":"Incidence of TCR and TCL1 gene translocations and isochromosome 7q in peripheral T-cell lymphomas using fluorescence in situ hybridization.","volume":"130","author":"Feldman","year":"2008","journal-title":"Am J Clin Pathol"},{"issue":"20","key":"2020071613014936700_B21","doi-asserted-by":"crossref","first-page":"3118","DOI":"10.1182\/blood-2014-05-578575","article-title":"The oncogenic transcription factor IRF4 is regulated by a novel CD30\/NF-\u03baB positive feedback loop in peripheral T-cell lymphoma.","volume":"125","author":"Boddicker","year":"2015","journal-title":"Blood"},{"issue":"6","key":"2020071613014936700_B22","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.devcel.2013.02.010","article-title":"Dynamin 2 potentiates invasive migration of pancreatic tumor cells through stabilization of the Rac1 GEF Vav1.","volume":"24","author":"Razidlo","year":"2013","journal-title":"Dev Cell"},{"issue":"1","key":"2020071613014936700_B23","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cell.2010.11.055","article-title":"Massive genomic rearrangement acquired in a single catastrophic event during cancer development.","volume":"144","author":"Stephens","year":"2011","journal-title":"Cell"},{"issue":"6521","key":"2020071613014936700_B24","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/374474a0","article-title":"Defective T-cell receptor signalling and positive selection of Vav-deficient CD4+ CD8+ thymocytes.","volume":"374","author":"Fischer","year":"1995","journal-title":"Nature"},{"issue":"3","key":"2020071613014936700_B25","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.coi.2005.04.003","article-title":"Vav-family proteins in T-cell signalling.","volume":"17","author":"Tybulewicz","year":"2005","journal-title":"Curr Opin Immunol"},{"issue":"1","key":"2020071613014936700_B26","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/PAP.0000000000000047","article-title":"Anaplastic large cell lymphomas: ALK positive, ALK negative, and primary cutaneous.","volume":"22","author":"Xing","year":"2015","journal-title":"Adv Anat Pathol"},{"issue":"321","key":"2020071613014936700_B27","doi-asserted-by":"crossref","first-page":"ra35","DOI":"10.1126\/scisignal.2004993","article-title":"The C-terminal SH3 domain contributes to the intramolecular inhibition of Vav family proteins.","volume":"7","author":"Barreira","year":"2014","journal-title":"Sci Signal"},{"issue":"3","key":"2020071613014936700_B28","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1083\/jcb.200107080","article-title":"Vav1\/Rac-dependent actin cytoskeleton reorganization is required for lipid raft clustering in T cells.","volume":"155","author":"Villalba","year":"2001","journal-title":"J Cell Biol"},{"issue":"50","key":"2020071613014936700_B29","doi-asserted-by":"crossref","first-page":"38257","DOI":"10.1074\/jbc.M608913200","article-title":"Vav1 acidic region tyrosine 174 is required for the formation of T cell receptor-induced microclusters and is essential in T cell development and activation.","volume":"281","author":"Miletic","year":"2006","journal-title":"J Biol Chem"},{"issue":"6612","key":"2020071613014936700_B30","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/385169a0","article-title":"Phosphotyrosine-dependent activation of Rac-1 GDP\/GTP exchange by the vav proto-oncogene product.","volume":"385","author":"Crespo","year":"1997","journal-title":"Nature"},{"issue":"7","key":"2020071613014936700_B31","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1038\/nri840","article-title":"VAV proteins as signal integrators for multi-subunit immune-recognition receptors.","volume":"2","author":"Turner","year":"2002","journal-title":"Nat Rev Immunol"},{"issue":"10","key":"2020071613014936700_B32","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1182\/blood-2015-11-683052","article-title":"Redundant and nonredundant roles for Cdc42 and Rac1 in lymphomas developed in NPM-ALK transgenic mice.","volume":"127","author":"Choudhari","year":"2016","journal-title":"Blood"},{"issue":"1","key":"2020071613014936700_B33","doi-asserted-by":"crossref","first-page":"640","DOI":"10.4049\/jimmunol.176.1.640","article-title":"Azathioprine suppresses ezrin-radixin-moesin-dependent T cell-APC conjugation through inhibition of Vav guanosine exchange activity on Rac proteins.","volume":"176","author":"Poppe","year":"2006","journal-title":"J Immunol"},{"issue":"8","key":"2020071613014936700_B34","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1172\/JCI16432","article-title":"CD28-dependent Rac1 activation is the molecular target of azathioprine in primary human CD4+ T lymphocytes.","volume":"111","author":"Tiede","year":"2003","journal-title":"J Clin Invest"},{"issue":"14","key":"2020071613014936700_B35","doi-asserted-by":"crossref","first-page":"2907","DOI":"10.1158\/0008-5472.CAN-14-3103","article-title":"Targeting Pancreatic Cancer Metastasis by Inhibition of Vav1, a Driver of Tumor Cell Invasion.","volume":"75","author":"Razidlo","year":"2015","journal-title":"Cancer Res"},{"issue":"10","key":"2020071613014936700_B36","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1097\/PAS.0000000000000309","article-title":"Intracellular TCR-signaling pathway: novel markers for lymphoma diagnosis and potential therapeutic targets.","volume":"38","author":"Agostinelli","year":"2014","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"2020071613014936700_B37","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/leu.2009.198","article-title":"Inhibition of Syk protein tyrosine kinase induces apoptosis and blocks proliferation in T-cell non-Hodgkin\u2019s lymphoma cell lines.","volume":"24","author":"Wilcox","year":"2010","journal-title":"Leukemia"},{"issue":"3","key":"2020071613014936700_B38","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3109\/10408363.2013.874403","article-title":"Non-receptor protein tyrosine kinases signaling pathways in normal and cancer cells.","volume":"51","author":"Gocek","year":"2014","journal-title":"Crit Rev Clin Lab Sci"},{"issue":"39","key":"2020071613014936700_B39","doi-asserted-by":"crossref","first-page":"26871","DOI":"10.1074\/jbc.M109.034272","article-title":"The lymphoma-associated fusion tyrosine kinase ITK-SYK requires pleckstrin homology domain-mediated membrane localization for activation and cellular transformation.","volume":"284","author":"Rigby","year":"2009","journal-title":"J Biol Chem"},{"issue":"12","key":"2020071613014936700_B40","doi-asserted-by":"crossref","first-page":"e1003997","DOI":"10.1371\/journal.pgen.1003997","article-title":"Comprehensive analysis of transcriptome variation uncovers known and novel driver events in T-cell acute lymphoblastic leukemia.","volume":"9","author":"Atak","year":"2013","journal-title":"PLoS Genet"},{"issue":"4","key":"2020071613014936700_B41","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1021\/jm401805h","article-title":"Design of potent and selective inhibitors to overcome clinical anaplastic lymphoma kinase mutations resistant to crizotinib.","volume":"57","author":"Huang","year":"2014","journal-title":"J Med Chem"},{"issue":"6","key":"2020071613014936700_B42","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1101\/gad.12.6.782","article-title":"Helios, a T cell-restricted Ikaros family member that quantitatively associates with Ikaros at centromeric heterochromatin.","volume":"12","author":"Hahm","year":"1998","journal-title":"Genes Dev"},{"issue":"2","key":"2020071613014936700_B43","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1038\/leu.2010.255","article-title":"Natural killer cell lymphoma shares strikingly similar molecular features with a group of non-hepatosplenic \u03b3\u03b4 T-cell lymphoma and is highly sensitive to a novel aurora kinase A inhibitor in vitro.","volume":"25","author":"Iqbal","year":"2011","journal-title":"Leukemia"},{"issue":"10","key":"2020071613014936700_B44","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1038\/leu.2008.191","article-title":"High-resolution analysis of chromosome copy number alterations in angioimmunoblastic T-cell lymphoma and peripheral T-cell lymphoma, unspecified, with single nucleotide polymorphism-typing microarrays.","volume":"22","author":"Fujiwara","year":"2008","journal-title":"Leukemia"},{"issue":"6","key":"2020071613014936700_B45","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1046\/j.1365-2141.2003.04216.x","article-title":"Over-expression of short isoforms of Helios in patients with adult T-cell leukaemia\/lymphoma.","volume":"120","author":"Fujii","year":"2003","journal-title":"Br J Haematol"},{"issue":"7-8","key":"2020071613014936700_B46","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.cancergen.2012.04.006","article-title":"HELIOS-BCL11B fusion gene involvement in a t(2;14)(q34;q32) in an adult T-cell leukemia patient.","volume":"205","author":"Fujimoto","year":"2012","journal-title":"Cancer Genet"},{"issue":"2","key":"2020071613014936700_B47","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1182\/blood-2014-12-614503","article-title":"Identification of a new subclass of ALK-negative ALCL expressing aberrant levels of ERBB4 transcripts.","volume":"127","author":"Scarf\u00f2","year":"2016","journal-title":"Blood"},{"issue":"21","key":"2020071613014936700_B48","doi-asserted-by":"crossref","first-page":"8899","DOI":"10.1158\/0008-5472.CAN-08-2568","article-title":"The anaplastic lymphoma kinase controls cell shape and growth of anaplastic large cell lymphoma through Cdc42 activation.","volume":"68","author":"Ambrogio","year":"2008","journal-title":"Cancer Res"},{"issue":"11","key":"2020071613014936700_B49","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1038\/ng.3415","article-title":"Integrated molecular analysis of adult T cell leukemia\/lymphoma.","volume":"47","author":"Kataoka","year":"2015","journal-title":"Nat Genet"},{"issue":"19","key":"2020071613014936700_B50","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.1038\/sj.onc.1210921","article-title":"Activation of Rac1 and the exchange factor Vav3 are involved in NPM-ALK signaling in anaplastic large cell lymphomas.","volume":"27","author":"Colomba","year":"2008","journal-title":"Oncogene"},{"issue":"6","key":"2020071613014936700_B51","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1038\/bcj.2011.19","article-title":"Inhibition of Rac controls NPM-ALK-dependent lymphoma development and dissemination.","volume":"1","author":"Colomba","year":"2011","journal-title":"Blood Cancer J"},{"issue":"2","key":"2020071613014936700_B52","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1158\/1535-7163.MCT-14-0102","article-title":"Inhibition of the GTPase Rac1 mediates the antimigratory effects of metformin in prostate cancer cells.","volume":"14","author":"Dirat","year":"2015","journal-title":"Mol Cancer Ther"},{"issue":"10","key":"2020071613014936700_B53","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1158\/1535-7163.MCT-15-0419","article-title":"R-Ketorolac Targets Cdc42 and Rac1 and Alters Ovarian Cancer Cell Behaviors Critical for Invasion and Metastasis.","volume":"14","author":"Guo","year":"2015","journal-title":"Mol Cancer Ther"},{"issue":"5","key":"2020071613014936700_B54","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.dld.2011.01.010","article-title":"Simvastatin stimulates apoptosis in cholangiocarcinoma by inhibition of Rac1 activity.","volume":"43","author":"Miller","year":"2011","journal-title":"Dig Liver Dis"},{"issue":"11","key":"2020071613014936700_B55","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.2174\/156802606777812095","article-title":"Structure-function based design of small molecule inhibitors targeting Rho family GTPases.","volume":"6","author":"Nassar","year":"2006","journal-title":"Curr Top Med Chem"},{"issue":"9","key":"2020071613014936700_B56","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1517\/17460441.2015.1058775","article-title":"Approaches of targeting Rho GTPases in cancer drug discovery.","volume":"10","author":"Lin","year":"2015","journal-title":"Expert Opin Drug Discov"},{"issue":"2","key":"2020071613014936700_B57","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/ng.2873","article-title":"Recurrent mutations in epigenetic regulators, RHOA and FYN kinase in peripheral T cell lymphomas.","volume":"46","author":"Palomero","year":"2014","journal-title":"Nat Genet"},{"issue":"2","key":"2020071613014936700_B58","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/ng.2872","article-title":"Somatic RHOA mutation in angioimmunoblastic T cell lymphoma.","volume":"46","author":"Sakata-Yanagimoto","year":"2014","journal-title":"Nat Genet"},{"issue":"4","key":"2020071613014936700_B59","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/ng.2916","article-title":"A recurrent inactivating mutation in RHOA GTPase in angioimmunoblastic T cell lymphoma.","volume":"46","author":"Yoo","year":"2014","journal-title":"Nat Genet"},{"issue":"1","key":"2020071613014936700_B60","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/ajh.24203","article-title":"A three-signal model of T-cell lymphoma pathogenesis.","volume":"91","author":"Wilcox","year":"2016","journal-title":"Am J Hematol"},{"issue":"44","key":"2020071613014936700_B61","doi-asserted-by":"crossref","first-page":"18939","DOI":"10.1073\/pnas.1013230107","article-title":"T-cell receptor-driven lymphomagenesis in mice derived from a reprogrammed T cell.","volume":"107","author":"Serwold","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"issue":"9","key":"2020071613014936700_B62","first-page":"6097","article-title":"Angioimmunoblastic T-cell lymphoma in Taiwan shows a frequent gain of ITK gene.","volume":"7","author":"Liang","year":"2014","journal-title":"Int J Clin Exp Pathol"},{"issue":"2","key":"2020071613014936700_B63","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1053\/j.seminhematol.2015.01.008","article-title":"B-cell receptor signaling in diffuse large B-cell lymphoma.","volume":"52","author":"Young","year":"2015","journal-title":"Semin Hematol"},{"issue":"3","key":"2020071613014936700_B64","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s12185-014-1522-1","article-title":"Molecular genetics of peripheral T-cell lymphomas.","volume":"99","author":"Piccaluga","year":"2014","journal-title":"Int J Hematol"},{"issue":"101","key":"2020071613014936700_B65","doi-asserted-by":"crossref","first-page":"ra83","DOI":"10.1126\/scisignal.2000420","article-title":"Function of the nucleotide exchange activity of vav1 in T cell development and activation.","volume":"2","author":"Saveliev","year":"2009","journal-title":"Sci Signal"},{"issue":"30","key":"2020071613014936700_B66","doi-asserted-by":"crossref","first-page":"23075","DOI":"10.1074\/jbc.M109.094508","article-title":"Tyrosine residues at the carboxyl terminus of Vav1 play an important role in regulation of its biological activity.","volume":"285","author":"Lazer","year":"2010","journal-title":"J Biol Chem"},{"issue":"16","key":"2020071613014936700_B67","doi-asserted-by":"crossref","first-page":"9014","DOI":"10.1073\/pnas.161281298","article-title":"Rac1 mediates STAT3 activation by autocrine IL-6.","volume":"98","author":"Faruqi","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"2020071613014936700_B68","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/nm1249","article-title":"Stat3 is required for ALK-mediated lymphomagenesis and provides a possible therapeutic target.","volume":"11","author":"Chiarle","year":"2005","journal-title":"Nat Med"},{"issue":"15","key":"2020071613014936700_B69","doi-asserted-by":"crossref","first-page":"3048","DOI":"10.1182\/blood-2012-06-435297","article-title":"STAT3 mutations unify the pathogenesis of chronic lymphoproliferative disorders of NK cells and T-cell large granular lymphocyte leukemia.","volume":"120","author":"Jerez","year":"2012","journal-title":"Blood"},{"issue":"10","key":"2020071613014936700_B70","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1182\/blood-2014-07-588970","article-title":"Receptor-type tyrosine-protein phosphatase \u03ba directly targets STAT3 activation for tumor suppression in nasal NK\/T-cell lymphoma.","volume":"125","author":"Chen","year":"2015","journal-title":"Blood"},{"issue":"10","key":"2020071613014936700_B71","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.1038\/jid.2014.199","article-title":"Exploring the IL-21-STAT3 axis as therapeutic target for S\u00e9zary syndrome.","volume":"134","author":"van der Fits","year":"2014","journal-title":"J Invest Dermatol"},{"issue":"1","key":"2020071613014936700_B72","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/ajmg.c.31387","article-title":"Implementing individualized medicine into the medical practice.","volume":"166C","author":"Lazaridis","year":"2014","journal-title":"Am J Med Genet C Semin Med Genet"},{"issue":"Suppl 1","key":"2020071613014936700_B73","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1159\/000431056","article-title":"Overview: A New Era of Cancer Genomics in Lymphoid Malignancies.","volume":"89","author":"Iida","year":"2015","journal-title":"Oncology"},{"issue":"20","key":"2020071613014936700_B74","doi-asserted-by":"crossref","first-page":"5240","DOI":"10.1158\/1078-0432.CCR-14-2020","article-title":"Changing the paradigms of treatment in peripheral T-cell lymphoma: from biology to clinical practice.","volume":"20","author":"O\u2019Connor","year":"2014","journal-title":"Clin Cancer Res"},{"issue":"1","key":"2020071613014936700_B75","first-page":"1","article-title":"Genetics of anaplastic large cell lymphoma.","volume":"57","author":"Zeng","year":"2015","journal-title":"Leuk Lymphoma"},{"key":"2020071613014936700_B76","author":"Swerdlow"},{"key":"2020071613014936700_B77","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.phrs.2013.11.002","article-title":"The ErbB\/HER family of protein-tyrosine kinases and cancer.","volume":"79","author":"Roskoski","year":"2014","journal-title":"Pharmacol Res"},{"issue":"1","key":"2020071613014936700_B78","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1093\/annonc\/mdv486","article-title":"Comprehensive serum cytokine analysis identifies IL-1RA and soluble IL-2R\u03b1 as predictors of event-free survival in T-cell lymphoma.","volume":"27","author":"Gupta","year":"2016","journal-title":"Ann Oncol"},{"key":"2020071613014936700_B79","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.1182\/blood.V126.23.2681.2681","article-title":"Mutations Targeting the ErbB Pathway and MSC in Peripheral T-Cell Lymphoma.","volume":"126","author":"Zimmermann","year":"2015","journal-title":"Blood"},{"issue":"6","key":"2020071613014936700_B80","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.ccr.2011.11.006","article-title":"Combined genetic inactivation of \u03b22-Microglobulin and CD58 reveals frequent escape from immune recognition in diffuse large B cell lymphoma.","volume":"20","author":"Challa-Malladi","year":"2011","journal-title":"Cancer Cell"},{"issue":"21","key":"2020071613014936700_B81","doi-asserted-by":"crossref","first-page":"6129","DOI":"10.1158\/0008-5472.CAN-14-0643","article-title":"Molecular characterization of chronic-type adult T-cell leukemia\/lymphoma.","volume":"74","author":"Yoshida","year":"2014","journal-title":"Cancer Res"},{"issue":"1","key":"2020071613014936700_B82","doi-asserted-by":"crossref","first-page":"91","DOI":"10.2217\/14796694.2.1.91","article-title":"Targeting GSK-3: a promising approach for cancer therapy?","volume":"2","author":"Ougolkov","year":"2006","journal-title":"Future Oncol"},{"issue":"50","key":"2020071613014936700_B83","doi-asserted-by":"crossref","first-page":"35283","DOI":"10.1074\/jbc.M805590200","article-title":"A novel germ cell-specific protein, SHIP1, forms a complex with chromatin remodeling activity during spermatogenesis.","volume":"283","author":"Choi","year":"2008","journal-title":"J Biol Chem"},{"issue":"6 Pt 1","key":"2020071613014936700_B84","doi-asserted-by":"crossref","first-page":"C1119","DOI":"10.1152\/ajpcell.1992.263.6.C1119","article-title":"Signal transduction by T-cell receptors: mobilization of Ca and regulation of Ca-dependent effector molecules.","volume":"263","author":"Premack","year":"1992","journal-title":"Am J Physiol"},{"issue":"10","key":"2020071613014936700_B85","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1038\/sj.onc.1210774","article-title":"The transcriptional repressor NIPP1 is an essential player in EZH2-mediated gene silencing.","volume":"27","author":"Nuytten","year":"2008","journal-title":"Oncogene"},{"issue":"7","key":"2020071613014936700_B86","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.3109\/10428194.2014.968780","article-title":"Enhancer of zeste homolog 2 is widely expressed in T-cell neoplasms, is associated with high proliferation rate and correlates with MYC and pSTAT3 expression in a subset of cases.","volume":"56","author":"Shi","year":"2015","journal-title":"Leuk Lymphoma"},{"issue":"3","key":"2020071613014936700_B87","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.ajpath.2012.05.015","article-title":"CD137 is expressed in follicular dendritic cell tumors and in classical Hodgkin and T-cell lymphomas: diagnostic and therapeutic implications.","volume":"181","author":"Anderson","year":"2012","journal-title":"Am J Pathol"},{"issue":"5","key":"2020071613014936700_B88","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1038\/leu.2015.357","article-title":"Recurrent activating mutations of CD28 in peripheral T-cell lymphomas.","volume":"30","author":"Rohr","year":"2016","journal-title":"Leukemia"},{"issue":"8","key":"2020071613014936700_B89","doi-asserted-by":"crossref","first-page":"2991","DOI":"10.1182\/blood.V91.8.2991.2991_2991_2997","article-title":"Hematopoietic malignancies demonstrate loss-of-function mutations of BAX.","volume":"91","author":"Meijerink","year":"1998","journal-title":"Blood"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/128\/9\/1234\/1398975\/1234.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/128\/9\/1234\/1398975\/1234.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,16]],"date-time":"2020-07-16T22:48:14Z","timestamp":1594939694000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/128\/9\/1234\/35791\/Integrated-matepair-and-RNA-sequencing-identifies"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,1]]},"references-count":89,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2016,9,1]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2016-03-707141","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,1]]}}}